Larimar Therapeutics, Inc.【LRMR】 利益剰余金の推移

(単位:千ドル) 利益剰余金 前年比(%)
1Q25 -298,400 +46.9%
4Q24 -269,200 +42.7%
3Q24 -240,300 +36.8%
2Q24 -224,800 +35.0%
1Q24 -203,200 +28.5%
4Q23 -188,600 +24.4%
3Q23 -175,600 +23.5%
2Q23 -166,500 +24.3%
1Q23 -158,100 +26.3%
4Q22 -151,600 +30.4%
3Q22 -142,200 +32.8%
2Q22 -133,900 +48.3%
1Q22 -125,200 +61.1%
4Q21 -116,300 +77.2%
3Q21 -107,100 +108.3%
2Q21 -90,300 +119.5%
1Q21 -77,702 -80.6%
4Q20 -65,614 -83.4%
3Q20 -51,410 -86.8%
2Q20 -41,136 -89.1%
1Q20 -399,949 +9.9%
4Q19 -396,351 +12.9%
3Q19 -389,100 +15.7%
2Q19 -376,186 +17.1%
1Q19 -364,057 +19.2%
4Q18 -350,945 +21.2%
3Q18 -336,375 +21.7%
2Q18 -321,308 +21.8%
1Q18 -305,533 +21.9%
4Q17 -289,577 +21.9%
3Q17 -276,492 +21.7%
2Q17 -263,907 +24.2%
1Q17 -250,560 +26.9%
4Q16 -237,549 +32.2%
3Q16 -227,110 +45.1%
2Q16 -212,435 +55.5%
1Q16 -197,407 +66.1%
4Q15 -179,671 +70.5%
3Q15 -156,497 +65.7%
2Q15 -136,613 +71.3%
1Q15 -118,857 -
4Q14 -105,385 -
3Q14 -94,454 -
2Q14 -79,765 -